Remove eli-lilly-aggressively-planning-manufacturing-expansions-ceo-says-mounjaro-soars
article thumbnail

Eli Lilly 'aggressively planning' manufacturing expansions, CEO says, as Mounjaro soars

Fierce Pharma

Supply problems for Eli Lilly’s diabetes med Mounjaro were no secret. As strong demand continues to push Mounjaro sales to new highs, Eli Lilly CEO David Ricks said the company is "not done with" manufacturing expansions.